1. "2004"
Formats
  1. Journal Article (1394)
  2. Meeting Abstract (554)
  3. Book Section (97)
  4. Conference Paper (14)
  5. Book Whole (6)
Groups
  1. Department of Medicine (558)
  2. Surgery (471)
  3. Sloan Kettering Institute Faculty (431)
  4. GSK Faculty (409)
  5. Solid Tumor Oncology Division (292)
  6. Survivorship Research (268)

More Groups

People
  1. Michael Kattan (43)
  2. Murray Brennan (42)
  3. Steven Larson (37)
  4. Peter Scardino (36)
  5. Carlos Cordon-Cardo (34)
  6. Michael Zelefsky (34)

More People

Years
  1. 2004 (2065)
Publications
  1. Journal of Clinical Oncology (170)
  2. Blood (94)
  3. Cancer Research (64)
  4. International Journal of Radiation Oncology, Biology, Physics (47)
  5. Medical Physics (36)
  6. Leibel and Phillips Textbook of Radiation Oncology. 2nd ed (35)

More Publications

Publishers
  1. Elsevier Inc. (261)
  2. American Society of Clinical Oncology (170)
  3. Lippincott Williams & Wilkins (126)
  4. Elsevier Science, Inc. (108)
  5. American Association for Cancer Research (106)
  6. Springer (105)

More Publishers

Results (2065)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Marked clinical activity of the novel proteasome inhibitor bortezomib in patients with relapsed follicular and mantle cell lymphoma
    Meeting Abstract

    O'Connor, O. A.
    Annals of Oncology (2004)

    Fulltext@MSK | Save
  • Marked clinical activity of the novel proteasome inhibitor bortezomib in patients with relapsed follicular (RL) and mantle cell lymphoma (MCL)
    Meeting Abstract

    O'Connor, O. A.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • A Multicenter experience with single agent bortezomib in non-Hodgkin's lymphoma reveals marked differences in sub-type sensitivity to proteasome inhibition
    Meeting Abstract

    O'connor, O.; Wright, J.; Moskowitz, C.; Macgregor-Cortelli, B.; Straus, D.; Evans, A.; Winter, J.; Koc, O.; Horvath, N.; Blumel, S.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Combined targeting of the proteasome and bcl-2 sensitizes human B-cell lymphoma and multiple myeloma to cyclophosphamide in in vitro and in vivo models of these diseases
    Meeting Abstract

    O'connor, O.; Toner, L.; Smith, E.; Srinivasan, S.; Hernandez, F.; Rolf, M.; Frankel, S.; Chanan-Khan, A.
    Blood (2004)

    Fulltext@MSK | Save
  • Treatment-seeking behavior and medication utilization of men with erectile dysfunction
    Meeting Abstract

    O'Brien, K.; Parker, M.; Guhring, P.; Mulhall, J. P.
    Journal of Sexual Medicine (2004)

    Fulltext@MSK | Save
  • Analysis of the natural history of Peyronie's disease
    Meeting Abstract

    O'Brien, K.; Parker, M.; Guhring, P.; Mulhall, J. P.
    Journal of Sexual Medicine (2004)

    Fulltext@MSK | Save
  • How to integrate new therapies to our current strategies
    Meeting Abstract

    Norton, L.
    EJC Supplements (2004)

    Fulltext@MSK | Save
  • Toward the development of molecular oncology: The integration of molecular epidemiology and environmental oncology
    Meeting Abstract

    Norton, L.
    Epidemiology (2004)

    Fulltext@MSK | Save
  • Hormonal induction followed by rapid hormonal cycling for prostate cancer (PC): The MEN's Cycle
    Meeting Abstract

    Nordquist, L.; Sauter, N.; Morris, M.; Smaletz, O.; Konopelski, K.; Delacruz, A.; Heller, G.; Scher, H. I.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Critical role of Dok-1 and Dok-2 in leukemia suppression
    Meeting Abstract

    Niki, M.; Di Cristofano, A.; Zhao, M. M.; Hirai, H.; Van Aelst, L.; Cordon-Cardo, C.; Pandolfi, P. P.
    Blood (2004)

    Fulltext@MSK | Save